One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

AIMS: To evaluate the maintenance of efficacy and safety of insulin glargine 300 U/ml (Gla-300) versus glargine 100 U/ml (Gla-100) in people with type 2 diabetes mellitus (T2DM) using basal plus meal-time insulin for 12 months in the EDITION 1 trial. METHODS: EDITION 1 was a multicentre, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Riddle, M C, Yki-Järvinen, H, Bolli, G B, Ziemen, M, Muehlen-Bartmer, I, Cissokho, S, Home, P D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676922/
https://www.ncbi.nlm.nih.gov/pubmed/25846721
http://dx.doi.org/10.1111/dom.12472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676922/
https://www.ncbi.nlm.nih.gov/pubmed/25846721
http://dx.doi.org/10.1111/dom.12472

Ejemplares similares